Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Jeffries

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2025
Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell DiseaseHenna Butt, Neal Jeffries, Triscia Martin, et al.
Journal of Neurosurgery|August 21, 2002
Epileptiform activity extinguished by amygdala infusion of the neurotoxin ibotenate in a rat model of temporal lobe epilepsyJohn R Pace, Russell R Lonser, R Duncan Kirkby, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Statistics in Medicine|February 28, 2024
Use of win time for ordered composite endpoints in clinical trialsJames F Troendle, Eric S Leifer, Song Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell DiseaseEmily Limerick, Matt Hsieh, Jackie Queen, et al.
Brain : a Journal of Neurology|June 25, 2003
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 yearsFrancesca Bagnato, Neal Jeffries, Nancy D Richert, et al.
Plos One|March 23, 2026
Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell diseaseEmily Limerick, Matthew Hsieh, Jackie Queen, et al.
British Journal of Haematology|February 3, 2021
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centresMohsen Alzahrani, Moussab Damlaj, Neal Jeffries, et al.
Bone Marrow Transplantation|March 23, 2025
Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell diseaseEmily Limerick, Matthew M Hsieh, Mauricio Barretto, et al.
Blood Advances|October 4, 2019
Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell diseaseVandana Sachdev, Matthew Hsieh, Neal Jeffries, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2025
Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell DiseaseHenna Butt, Neal Jeffries, Triscia Martin, et al.
Journal of Neurosurgery|August 21, 2002
Epileptiform activity extinguished by amygdala infusion of the neurotoxin ibotenate in a rat model of temporal lobe epilepsyJohn R Pace, Russell R Lonser, R Duncan Kirkby, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Statistics in Medicine|February 28, 2024
Use of win time for ordered composite endpoints in clinical trialsJames F Troendle, Eric S Leifer, Song Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell DiseaseEmily Limerick, Matt Hsieh, Jackie Queen, et al.
Brain : a Journal of Neurology|June 25, 2003
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 yearsFrancesca Bagnato, Neal Jeffries, Nancy D Richert, et al.
Plos One|March 23, 2026
Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell diseaseEmily Limerick, Matthew Hsieh, Jackie Queen, et al.
British Journal of Haematology|February 3, 2021
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centresMohsen Alzahrani, Moussab Damlaj, Neal Jeffries, et al.
Bone Marrow Transplantation|March 23, 2025
Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell diseaseEmily Limerick, Matthew M Hsieh, Mauricio Barretto, et al.
Blood Advances|October 4, 2019
Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell diseaseVandana Sachdev, Matthew Hsieh, Neal Jeffries, et al.
Pageof 6